Thalamuthu, Anbupalam
Mills, Natalie T. http://orcid.org/0000-0003-3255-5118
Berger, Klaus
Minnerup, Heike
Grotegerd, Dominik
Dannlowski, Udo
Meinert, Susanne
Opel, Nils
Repple, Jonathan
Gruber, Marius
Nenadić, Igor
Stein, Frederike
Brosch, Katharina
Meller, Tina
Pfarr, Julia-Katharina
Forstner, Andreas J. http://orcid.org/0000-0002-1876-6368
Hoffmann, Per
Nöthen, Markus M. http://orcid.org/0000-0002-8770-2464
Witt, Stephanie http://orcid.org/0000-0002-1571-1468
Rietschel, Marcella http://orcid.org/0000-0002-5236-6149
Kircher, Tilo
Adams, Mark http://orcid.org/0000-0002-3599-6018
McIntosh, Andrew M. http://orcid.org/0000-0002-0198-4588
Porteous, David J. http://orcid.org/0000-0003-1249-6106
Deary, Ian J. http://orcid.org/0000-0002-1733-263X
Hayward, Caroline http://orcid.org/0000-0002-9405-9550
Campbell, Archie http://orcid.org/0000-0003-0198-5078
Grabe, Hans Jörgen http://orcid.org/0000-0003-3684-4208
Teumer, Alexander http://orcid.org/0000-0002-8309-094X
Homuth, Georg
van der Auwera-Palitschka, Sandra http://orcid.org/0000-0002-1757-7768
Schubert, K. Oliver http://orcid.org/0000-0003-1690-0209
Baune, Bernhard T.
Article History
Received: 7 June 2021
Revised: 8 October 2021
Accepted: 26 October 2021
First Online: 15 November 2021
Change Date: 5 June 2023
Change Type: Update
Change Details: The incorrect family name captured in the tagging for K. Oliver Schubert.
Competing interests
: HJG has received travel grants and speaker honoraria from Fresenius Medical Care, Neuraxpharm, Servier and Janssen Cilag as well as research funding from Fresenius Medical Care. KOS reports having received lecture fees and research funding from Janssen Australia, research funding from Lundbeck Otsuka, and research funding from Gilead. BTB reports having received speaker and consultation fees from AstraZeneca, Lundbeck, Pfizer, Takeda, Servier, Bristol Myers Squibb, Otsuka, LivaNova and Janssen-Cilag. The other authors declare no competing interests.